Published in
Taylor and Francis Group, Leukemia & Lymphoma, 1(61), p. 84-90, 2019
DOI: 10.1080/10428194.2019.1658102
Links
Tools
Dexamethasone, oxaliplatin and cytarabine (R-DHAOx) as salvage and stem cells mobilizing therapy in relapsed/refractory diffuse large B cell lymphomas
Journal article published in 2019 by
Lorenzo Manconi 
,
Elisa Coviello,
Filippo Canale,
Livia Giannoni,
Paola Minetto,
Fabio Guolo,
Marino Clavio,
Riccardo Marcolin,
Michele Cea,
Antonia Cagnetta,
Marco Gobbi,
Maurizio Miglino,
Filippo Ballerini ,
Roberto Massimo Lemoli
,
Elisa Coviello,
Filippo Canale,
Livia Giannoni,
Paola Minetto,
Fabio Guolo,
Marino Clavio,
Riccardo Marcolin,
Michele Cea,
Antonia Cagnetta,
Marco Gobbi,
Maurizio Miglino,
Filippo Ballerini ,
Roberto Massimo Lemoli
Distributing this paper is prohibited by the publisher
Full text: Unavailable
Preprint: archiving forbidden
Published version:
archiving forbidden
Data provided by 